Elite Pharmaceuticals Market Cap

Elite Pharmaceuticals has a market cap or net worth of $521.6 million as of December 22, 2025. Its market cap has decreased by -17.88% in one year.

Market Cap

521.60M

Enterprise Value

501.27M

Revenue

122.89M

Ranking

n/a

PE Ratio

37.29

Stock Price

$0.49

Market Cap Chart

Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 521.60M, an increase of 5,347.34%. That is a compound annual growth rate of 15.69%.

Market Cap History

Date	Market Cap	% Change
Dec 19, 2025	521.60M	-9.77%
Dec 31, 2024	578.04M	306.60%
Dec 29, 2023	142.16M	374.74%
Dec 30, 2022	29.95M	-10.40%
Dec 31, 2021	33.42M	-36.49%
Dec 31, 2020	52.63M	-31.72%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	820.05M
Glass House Brands	755.14M
Northwest Biotherapeutics	395.14M
CytoDyn	358.49M
Silence Therapeutics	300.88M
Nika Pharmaceuticals	291.10M
American Oncology Network	190.62M
HST Global	131.71M

Market Cap Rankings